AU2001245550A1 - Applications of immune system tolerance to treatment of various diseases - Google Patents

Applications of immune system tolerance to treatment of various diseases

Info

Publication number
AU2001245550A1
AU2001245550A1 AU2001245550A AU4555001A AU2001245550A1 AU 2001245550 A1 AU2001245550 A1 AU 2001245550A1 AU 2001245550 A AU2001245550 A AU 2001245550A AU 4555001 A AU4555001 A AU 4555001A AU 2001245550 A1 AU2001245550 A1 AU 2001245550A1
Authority
AU
Australia
Prior art keywords
applications
treatment
immune system
various diseases
system tolerance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245550A
Inventor
Lee Walters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001245550A1 publication Critical patent/AU2001245550A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
AU2001245550A 2000-03-09 2001-03-09 Applications of immune system tolerance to treatment of various diseases Abandoned AU2001245550A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18812400P 2000-03-09 2000-03-09
US60/188,124 2000-03-09
PCT/US2001/007546 WO2001065934A2 (en) 2000-03-09 2001-03-09 Applications of immune system tolerance to treatment of various diseases

Publications (1)

Publication Number Publication Date
AU2001245550A1 true AU2001245550A1 (en) 2001-09-17

Family

ID=22691862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245550A Abandoned AU2001245550A1 (en) 2000-03-09 2001-03-09 Applications of immune system tolerance to treatment of various diseases

Country Status (3)

Country Link
US (1) US20010053362A1 (en)
AU (1) AU2001245550A1 (en)
WO (1) WO2001065934A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460367B2 (en) 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
CA2400319C (en) * 2000-03-15 2008-09-16 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
CA2486621A1 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
AU2003259152A1 (en) * 2002-07-23 2004-02-09 Boston Scientific Limited Cell therapy for regeneration
JP2006500956A (en) * 2002-10-01 2006-01-12 デューク・ユニバーシティ Targeted tumor therapy by using recombinant adenoviral vectors that selectively replicate in the hypoxic region of the tumor
ES2597837T3 (en) 2003-06-27 2017-01-23 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of manufacturing and using them
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
WO2005107817A2 (en) 2004-04-30 2005-11-17 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US20070202077A1 (en) * 2005-12-02 2007-08-30 Brodsky Robert A Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders
WO2007070870A1 (en) 2005-12-16 2007-06-21 Ethicon, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2008034071A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
US20080294107A1 (en) * 2007-05-22 2008-11-27 Convergent Medical Solutions, Inc. Multiple robotic injections of prenatal medications based on scanned image
MX2010003548A (en) * 2007-10-01 2010-06-02 Univ Johns Hopkins Methods of treating neurological autoimmune disorders with cyclophosphamide.
WO2009067690A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for safe and effective treatment using oxazaphosphorine drugs
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
EP3681501A1 (en) * 2017-09-15 2020-07-22 The Board of Trustees of the Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators for protecting, expanding and increasing the potency of hematopoietic stem cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0700297B1 (en) * 1993-05-24 2002-07-31 Ximerex, Inc. Surrogate tolerogenesis for the development of tolerance to xenografts

Also Published As

Publication number Publication date
US20010053362A1 (en) 2001-12-20
WO2001065934A2 (en) 2001-09-13
WO2001065934A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2001245550A1 (en) Applications of immune system tolerance to treatment of various diseases
AU2002225512A1 (en) Immune system stimulation
HUP0301815A3 (en) Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment
IL145470A0 (en) Compositions for the treatment of immune diseases
AU2002366804A1 (en) Methods to reduce body fat
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
HUP0401392A3 (en) Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2002365837A1 (en) Interface to operate groups of inputs/outputs
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2001232053A1 (en) System for the extracorporeal treatment of blood
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003260818A1 (en) Treatment of immune system dysfunction
AU2002365281A1 (en) Thiochromenones used to combat painful conditions and neurodegenerative diseases
AU1405001A (en) Treatment of diseases
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002214950A1 (en) Determination of the ability of patients to respond to tumour treatment
AU2001282277A1 (en) Treatment of mycobacterial infection
AU5812601A (en) Treatment of il-10 deficiencies
AU2002360523A1 (en) Compounds to treat hiv infection and aids
AU2001273348A1 (en) Purification of human troponin i
AU2002251271A1 (en) Stimulation of the immune system